Rejection of Disseminated Metastases of Colon Carcinoma by Synergism of IL-12 Gene Therapy and 4-1BB Costimulation
Open Access
- 31 July 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 2 (1) , 39-46
- https://doi.org/10.1006/mthe.2000.0086
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- NK1.1 Cells Express 4-1BB (CDw137) Costimulatory Molecule and Are Required for Tumor Immunity Elicited by Anti-4-1BB Monoclonal AntibodiesCellular Immunology, 1998
- Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumorsGene Therapy, 1998
- Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumorsNature Medicine, 1997
- Phenotypic and functional characteristics of in vivo-induced interleukin-12-activated killer cellsImmunology Letters, 1995
- Interleukin-12: A Proinflammatory Cytokine with Immunoregulatory Functions that Bridge Innate Resistance and Antigen-Specific Adaptive ImmunityAnnual Review of Immunology, 1995
- Activation of the Human Immature Natural Killer Cell Subset by IL-12 and Its Regulation by Endogenous TNF-α and IFN-γ SecretionCellular Immunology, 1994
- The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and deathCell, 1994
- 4‐1BB T‐cell antigen binds to mature B cells and macrophages, and costimulates anti‐μ‐primed splenic B cellsEuropean Journal of Immunology, 1994
- Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factorEuropean Journal of Immunology, 1993
- IL-12: Initiation Cytokine for Cell-Mediated ImmunityScience, 1993